UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Tumor necrosis factor‐alpha inhibitors and risk of non‐Hodgkin lymphoma in a cohort of adults with rheumatologic conditions

International journal of cancer, 2018-09, Vol.143 (5), p.1062-1071

2018

Link zum Volltext

Verfügbarkeit prüfen

LABS: linear amplification-based bisulfite sequencing for ultrasensitive cancer detection from cell-free DNA

Genome Biology, 2024-06, Vol.25 (1), p.1-18, Article 157

2024

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma

Journal of hematology and oncology, 2022-08, Vol.15 (1), p.1-106, Article 106

2022

Link zum Volltext

Verfügbarkeit prüfen

Alterations of 5-hydroxymethylation in circulating cell-free DNA reflect molecular distinctions of subtypes of non-Hodgkin lymphoma

Npj genomic medicine, 2021-02, Vol.6 (1), p.11-11, Article 11

2021

Link zum Volltext

Verfügbarkeit prüfen

Physical functioning, frailty and risks of locally-advanced breast cancer among older women

Breast (Edinburgh), 2022-08, Vol.64, p.19-28

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment of older patients with diffuse large B-cell lymphoma and mild cognitive impairment or dementia

Journal of geriatric oncology, 2019-05, Vol.10 (3), p.510-513

2019

Link zum Volltext

Verfügbarkeit prüfen

Self-reported health and survival in older patients diagnosed with multiple myeloma

Cancer causes & control, 2020-07, Vol.31 (7), p.641-650

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma

Blood advances, 2019-10, Vol.3 (19), p.2790-2799

2019

Link zum Volltext

Verfügbarkeit prüfen

Application of the High-throughput TAB-Array for the Discovery of Novel 5-Hydroxymethylcytosine Biomarkers in Pancreatic Ductal Adenocarcinoma

Epigenomes, 2019-09, Vol.3 (3), p.16

2019

Link zum Volltext

Verfügbarkeit prüfen

Real-World Validity of the Revised International Staging System in Multiple Myeloma By Race

Blood, 2020-11, Vol.136 (Supplement 1), p.40-41

2020

Link zum Volltext

Verfügbarkeit prüfen

Development of an Inclusive Risk Prognostic Index for Newly Diagnosed Multiple Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.3789-3789

2021

Link zum Volltext

Verfügbarkeit prüfen

Racial Disparities in the Diagnostic Evaluation of Multiple Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.4116-4116

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract PR09: Racial disparities in health insurance status of U.S. adults with hematologic malignancies in states with and without Medicaid expansion: Analyses from the National Cancer Database, 2007-2016

Cancer epidemiology, biomarkers & prevention, 2020-06, Vol.29 (6_Supplement_2), p.PR09-PR09

2020

Link zum Volltext

Verfügbarkeit prüfen

Racial Differences in High-Risk Cytogenetic Mutations and Outcomes in Multiple Myeloma

Blood, 2019-11, Vol.134 (Supplement_1), p.5494-5494

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract PR03: Genome-wide 5-hydroxymethylcytosine profiles in circulating cell-free DNA and survival in patients with multiple myeloma

Clinical cancer research, 2020-06, Vol.26 (11_Supplement), p.PR03-PR03

2020

Link zum Volltext

Verfügbarkeit prüfen

A pilot study of vitamin D, calcium, and percent breast density in Hispanic women

Nutrition research (New York, N.Y.), 2006, Vol.26 (1), p.11-15

2006

Link zum Volltext

Verfügbarkeit prüfen

Racial differences in intravenous bisphosphonate utilization among older patients with multiple myeloma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e18165-e18165

2019

Link zum Volltext

Verfügbarkeit prüfen

Adherence and cumulative bisphosphonate dose in relation to risk of skeletal-related events among older patients with multiple myeloma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e18250-e18250

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5748: Declines in health-related quality of life among older patients diagnosed with hematologic malignancies

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5748-5748

2020

Link zum Volltext

Verfügbarkeit prüfen

Racial and Age-Related Differences in Impacts of High-Risk Cytogenetic Abnormalities on Survival in Multiple Myeloma in a Nationwide Electronic Health Record-Derived Database

Blood, 2021-11, Vol.138 (Supplement 1), p.4121-4121

2021

Link zum Volltext

Verfügbarkeit prüfen

Venous Thromboembolic Prophylaxis Following Treatment Initiation for Multiple Myeloma

Blood, 2018-11, Vol.132 (Supplement 1), p.4693-4693

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract D092: Racial disparities in HIV-associated lymphoma

Cancer epidemiology, biomarkers & prevention, 2020-06, Vol.29 (6_Supplement_2), p.D092-D092

2020

Link zum Volltext

Verfügbarkeit prüfen

5-Hydroxymethylcytosines of Circulating Cell-Free DNA and Prognosis in Diffuse Large B-Cell Lymphoma

Blood, 2018-11, Vol.132 (Supplement 1), p.2985-2985

2018

Link zum Volltext

Verfügbarkeit prüfen

Racial Differences in Long-Term Risk of Venous Thromboembolism Among Older Patients Following Diagnosis and Treatment of Multiple Myeloma

Blood, 2016-12, Vol.128 (22), p.2071-2071

2016

Link zum Volltext

Verfügbarkeit prüfen

Biologic Disease-Modifying Antirheumatic Drugs and Risk of Multiple Myeloma

Blood, 2018-11, Vol.132 (Supplement 1), p.1888-1888

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(61)
Reviews
(1)

Sprache

Englisch
(61)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tumor necrosis factor‐alpha inhibitors and risk of non‐Hodgkin lymphoma in a cohort of adults with rheumatologic conditions

LABS: linear amplification-based bisulfite sequencing for ultrasensitive cancer detection from cell-free DNA

Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma

Alterations of 5-hydroxymethylation in circulating cell-free DNA reflect molecular distinctions of subtypes of non-Hodgkin lymphoma

Physical functioning, frailty and risks of locally-advanced breast cancer among older women

Treatment of older patients with diffuse large B-cell lymphoma and mild cognitive impairment or dementia

Self-reported health and survival in older patients diagnosed with multiple myeloma

Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma

Application of the High-throughput TAB-Array for the Discovery of Novel 5-Hydroxymethylcytosine Biomarkers in Pancreatic Ductal Adenocarcinoma

Real-World Validity of the Revised International Staging System in Multiple Myeloma By Race

Development of an Inclusive Risk Prognostic Index for Newly Diagnosed Multiple Myeloma

Racial Disparities in the Diagnostic Evaluation of Multiple Myeloma

Abstract PR09: Racial disparities in health insurance status of U.S. adults with hematologic malignancies in states with and without Medicaid expansion: Analyses from the National Cancer Database, 2007-2016

Racial Differences in High-Risk Cytogenetic Mutations and Outcomes in Multiple Myeloma

Abstract PR03: Genome-wide 5-hydroxymethylcytosine profiles in circulating cell-free DNA and survival in patients with multiple myeloma

A pilot study of vitamin D, calcium, and percent breast density in Hispanic women

Racial differences in intravenous bisphosphonate utilization among older patients with multiple myeloma

Adherence and cumulative bisphosphonate dose in relation to risk of skeletal-related events among older patients with multiple myeloma

Abstract 5748: Declines in health-related quality of life among older patients diagnosed with hematologic malignancies

Racial and Age-Related Differences in Impacts of High-Risk Cytogenetic Abnormalities on Survival in Multiple Myeloma in a Nationwide Electronic Health Record-Derived Database

Venous Thromboembolic Prophylaxis Following Treatment Initiation for Multiple Myeloma

Abstract D092: Racial disparities in HIV-associated lymphoma

5-Hydroxymethylcytosines of Circulating Cell-Free DNA and Prognosis in Diffuse Large B-Cell Lymphoma

Racial Differences in Long-Term Risk of Venous Thromboembolism Among Older Patients Following Diagnosis and Treatment of Multiple Myeloma

Biologic Disease-Modifying Antirheumatic Drugs and Risk of Multiple Myeloma

Aktive Filter

Suchergebnisse filtern